Tumor necrosis factor-alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome

M Tesauro, Francesca Schinzari, V Rovella, Domenico Melina, Nadia Mores, Angelina Barini, Marco Mettimano, D Lauro, M Iantorno, Mj Quon, Carmine Cardillo

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

38 Citazioni (Scopus)


OBJECTIVE: Obesity is associated with chronic inflammation due to overproduction of proinflammatory cytokines, including tumor necrosis factor (TNF)-alpha. We assessed the effects of TNF-alpha neutralization by infliximab on vascular reactivity during hyperinsulinemia in obesity-related metabolic syndrome. RESEARCH DESIGN AND METHODS: Vascular responses to intra-arterial infusion of acetylcholine (ACh) and sodium nitroprusside (SNP) were assessed in patients with metabolic syndrome, before and after administration of infliximab. RESULTS: Patients had blunted vasodilator responses to ACh and SNP during hyperinsulinemia compared with control subjects; a potentiation of the responsiveness to both ACh and SNP, however, was observed in patients following infliximab. The antioxidant vitamin C improved the vasodilator response to ACh in patients with metabolic syndrome, but its effect was not further enhanced by concurrent administration of infliximab. CONCLUSIONS: TNF-alpha neutralization ameliorates vascular reactivity in metabolic syndrome during hyperinsulinemia, likely in relation to decreased oxidative stress, thereby suggesting an involvement of inflammatory cytokines in vascular dysfunction of these patients.
Lingua originaleEnglish
pagine (da-a)1439-1441
Numero di pagine3
RivistaDiabetes Care
Stato di pubblicazionePubblicato - 2008


  • endothelium


Entra nei temi di ricerca di 'Tumor necrosis factor-alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome'. Insieme formano una fingerprint unica.

Cita questo